论文部分内容阅读
世界抗感染药物市场重心正由头孢菌素类药物向氟喹诺酮类药物转移 ,氟喹诺酮类药物成为抗生素药物中发展最快的领域。我国氟喹诺酮类原料药的市场前景不仅取决于国际的竞争 ,还在于是否能够把握“重磅炸弹”专利药物过期的契机与同类药物的更迭。氟喹诺酮类原料药企业需要结合自身产品战略 ,分析竞争形势 ,合理调整产品线 ,以获得更强竞争优势。
The focus of the world anti-infectives market is shifting from cephalosporins to fluoroquinolones, and fluoroquinolones have become the fastest-growing areas for antibiotics. The market prospect of fluoroquinolones in China depends not only on the international competition but also on the chances of expiration of “blockbuster” patented drugs and the change of similar drugs. Fluoroquinolones API companies need to combine their own product strategy, analysis of the competitive situation, a reasonable adjustment of product lines in order to obtain a stronger competitive advantage.